Galera Therapeutics, Inc. — Form D

Galera Therapeutics, Inc. of MALVERN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2025-01-14. The offering totals $2.9M, of which $2.9M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Lawrence Mel AllevaDirectorMalvern, PA
Nancy T ChangDirectorMalvern, PA
Michael R FriedmanDirectorMalvern, PA
Kevin R LokayDirectorMalvern, PA
J. Mel SorensenDirectorMalvern, PA
J. Mel SorensenExecutive OfficerMalvern, PA
Joel Mel SussmanExecutive OfficerMalvern, PA
Robert A BeardsleyDirectorGrand Rapids, MI
Robert A BeardsleyExecutive OfficerGrand Rapids, MI
Robert BeardsleyDirectorSt. Louis, MO
Robert BeardsleyExecutive OfficerSt. Louis, MO
Michal A SilverbergDirectorMalvern, PA
Thomas A DyrbergDirectorMalvern, PA
Stephen T RossExecutive OfficerMalvern, PA
Arthur T FratamicoExecutive OfficerMalvern, PA
Joel A SussmanExecutive OfficerMalvern, PA
Dennis P RileyExecutive OfficerMalvern, PA
Jon T HolmlundExecutive OfficerMalvern, PA
Michael A PowellDirectorMalvern, PA
Campbell A MurrayDirectorMalvern, PA
Frank A TortiDirectorMenlo Park, CA
Robert J CalcaterraDirectorSt. Louis, MO
James T BarrettDirectorMalvern, PA
Frank T TortiDirectorMalvern, PA
Campbell T MurrayDirectorMalvern, PA

Other filings by this issuer (6)

FiledFormOfferingSold
2025-01-13D$2.7M$2.7M
2018-09-17D$70.2M$70.2M
2016-11-28D$15.0M$15.0M
2015-10-14D$37.1M$37.1M
2014-08-06D$9.5M$4.7M
2012-12-10D$11.0M$11.0M

More